GTC
PRVB

Ghost Tree Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Ghost Tree Capital’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400,000
Closed -$4.23M – 65
2022
Q4 		$4.23M Buy
+400,000
New +$3.23M 1.81% 21
2021
Q4 		– Sell
-50,000
Closed -$320K – 71
2021
Q3 		$320K Sell
50,000
-50,000
-50% -$321K 0.09% 60
2021
Q2 		$843K Buy
+100,000
New +$807K 0.23% 51

Other funds holding PRVB

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Ghost Tree Capital's PRVB Position: Q1 2023 in Review

Ghost Tree Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2023, closing a stake of 400,000 shares — an estimated $4.23M sold.

Ghost Tree Capital first reported a position in PRVB in Q2 2021 and held it in 3 quarters. The position peaked at $4.23M in Q4 2022. 182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

  • Ghost Tree Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 400,000 Provention Bio, Inc. Common Stock shares in Q1 2023, an estimated $4.23M.
  • Ghost Tree Capital first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Ghost Tree Capital's Provention Bio, Inc. Common Stock position peaked at $4.23M in Q4 2022.
  • 182 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2023.

Based on Ghost Tree Capital's 13F filing for Q1 2023, filed 15 May 2023.